ATE493134T1 - Gefriergetrocknetes präparat mit methylcobalamin und verfahren zu seiner herstellung - Google Patents
Gefriergetrocknetes präparat mit methylcobalamin und verfahren zu seiner herstellungInfo
- Publication number
- ATE493134T1 ATE493134T1 AT04731472T AT04731472T ATE493134T1 AT E493134 T1 ATE493134 T1 AT E493134T1 AT 04731472 T AT04731472 T AT 04731472T AT 04731472 T AT04731472 T AT 04731472T AT E493134 T1 ATE493134 T1 AT E493134T1
- Authority
- AT
- Austria
- Prior art keywords
- freeze
- dried preparation
- methylcobalamin
- preparation containing
- excipient
- Prior art date
Links
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 title abstract 4
- 235000007672 methylcobalamin Nutrition 0.000 title abstract 4
- 239000011585 methylcobalamin Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 4
- 150000005846 sugar alcohols Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003129251 | 2003-05-07 | ||
| PCT/JP2004/005973 WO2004098614A1 (ja) | 2003-05-07 | 2004-05-06 | メチルコバラミン含有凍結乾燥製剤及びその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE493134T1 true ATE493134T1 (de) | 2011-01-15 |
Family
ID=33432069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04731472T ATE493134T1 (de) | 2003-05-07 | 2004-05-06 | Gefriergetrocknetes präparat mit methylcobalamin und verfahren zu seiner herstellung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060247203A1 (de) |
| EP (1) | EP1621202B1 (de) |
| JP (1) | JP4753717B2 (de) |
| KR (1) | KR100732100B1 (de) |
| CN (1) | CN100376251C (de) |
| AT (1) | ATE493134T1 (de) |
| AU (1) | AU2004236603B2 (de) |
| CA (1) | CA2521928A1 (de) |
| DE (1) | DE602004030781D1 (de) |
| ES (1) | ES2356242T3 (de) |
| WO (1) | WO2004098614A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI334866B (en) * | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
| CA2659562A1 (en) * | 2006-08-14 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Stable lyophilized preparation |
| AU2008211950A1 (en) | 2007-01-29 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same |
| CU24142B1 (es) * | 2010-10-29 | 2015-12-23 | Troikaa Pharmaceuticals Ltd | Composiciones nasales de vitamina b12 |
| CN102895200B (zh) * | 2012-11-02 | 2014-04-02 | 湖北人民制药有限公司 | 甲钴胺冻干组合物及其制备方法 |
| CN107595877B (zh) * | 2016-07-12 | 2020-08-28 | 石药集团恩必普药业有限公司 | 一种含有丁苯酞的药物组合物及其在治疗als病药物中的应用 |
| CN111556752A (zh) | 2017-12-28 | 2020-08-18 | 富士胶片富山化学株式会社 | 冻干制剂的制造方法 |
| JP7436151B2 (ja) * | 2019-05-31 | 2024-02-21 | 小林製薬株式会社 | ビタミンb12類の光安定化方法 |
| CN112494436A (zh) * | 2020-12-14 | 2021-03-16 | 卓和药业集团有限公司 | 一种注射用甲钴胺及其制备工艺 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7028M (de) * | 1966-06-23 | 1969-06-09 | ||
| JPS55113721A (en) * | 1979-02-27 | 1980-09-02 | Eisai Co Ltd | Immunity regulator |
| JPS59152327A (ja) * | 1983-02-16 | 1984-08-31 | Otsuka Pharmaceut Co Ltd | 安定な静注用総合ビタミン製剤 |
| JPS62149619A (ja) * | 1985-09-05 | 1987-07-03 | Teijin Ltd | 活性型ビタミンd3類注射用組成物 |
| FR2740686B1 (fr) * | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| FR2740973B1 (fr) * | 1995-11-15 | 1998-02-06 | Lipha | Nouvelle forme d'administration de l'hydroxocobalamine et son utilisation dans les intoxications par les cyanures |
| US6274564B1 (en) * | 1996-09-18 | 2001-08-14 | William J. Sarill | Compositions of cobalamin and related corrinoids, and uses thereof |
| JP3889844B2 (ja) * | 1997-02-10 | 2007-03-07 | 龍兒 梶 | 筋萎縮性側索硬化症治療剤 |
| US20020042394A1 (en) * | 2000-05-31 | 2002-04-11 | Hogenkamp Henricus P.C. | Cobalamin compounds useful as antibiotic agents and as imaging agents |
-
2004
- 2004-05-06 CA CA002521928A patent/CA2521928A1/en not_active Abandoned
- 2004-05-06 DE DE602004030781T patent/DE602004030781D1/de not_active Expired - Lifetime
- 2004-05-06 CN CNB2004800121087A patent/CN100376251C/zh not_active Expired - Lifetime
- 2004-05-06 KR KR1020057020988A patent/KR100732100B1/ko not_active Expired - Lifetime
- 2004-05-06 ES ES04731472T patent/ES2356242T3/es not_active Expired - Lifetime
- 2004-05-06 EP EP04731472A patent/EP1621202B1/de not_active Expired - Lifetime
- 2004-05-06 AT AT04731472T patent/ATE493134T1/de not_active IP Right Cessation
- 2004-05-06 US US10/555,343 patent/US20060247203A1/en not_active Abandoned
- 2004-05-06 JP JP2005505980A patent/JP4753717B2/ja not_active Expired - Lifetime
- 2004-05-06 WO PCT/JP2004/005973 patent/WO2004098614A1/ja not_active Ceased
- 2004-05-06 AU AU2004236603A patent/AU2004236603B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2004098614A1 (ja) | 2006-07-13 |
| KR100732100B1 (ko) | 2007-06-27 |
| DE602004030781D1 (de) | 2011-02-10 |
| CN1784237A (zh) | 2006-06-07 |
| AU2004236603B2 (en) | 2006-12-07 |
| JP4753717B2 (ja) | 2011-08-24 |
| KR20060011987A (ko) | 2006-02-06 |
| CA2521928A1 (en) | 2004-11-18 |
| US20060247203A1 (en) | 2006-11-02 |
| EP1621202A1 (de) | 2006-02-01 |
| CN100376251C (zh) | 2008-03-26 |
| WO2004098614A1 (ja) | 2004-11-18 |
| EP1621202A4 (de) | 2007-10-31 |
| EP1621202B1 (de) | 2010-12-29 |
| ES2356242T3 (es) | 2011-04-06 |
| AU2004236603A1 (en) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003041496A1 (en) | Transgenic animal | |
| CA2417727A1 (en) | Fentanyl composition for nasal administration | |
| ZA969249B (en) | A method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof. | |
| WO2005019256A3 (en) | Muteins of tear lipocalin | |
| MXPA05007516A (es) | Derivados de hexahidropirazino[1,2-a]pirimidina -4, 7-diona sustituidos, metodo para producirlos y su uso como medicamentos. | |
| IL186655A (en) | Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations and a process for purification of natural polymer having xyloglucan structure | |
| NO20022442L (no) | Legemidler for sykdommer i forbindelse med reduksjon i benmasse | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| ATE493134T1 (de) | Gefriergetrocknetes präparat mit methylcobalamin und verfahren zu seiner herstellung | |
| WO2006078659A3 (en) | Stable prostaglandin-containing compositions | |
| ATE400257T1 (de) | Stabile pharmazeutische zusammensetzung mit linezolid form iv | |
| WO2006052876A3 (en) | Insecticidal compositions suitable for use in preparation of insecticidal granular fertilizer and insecticidal formulations | |
| WO2005041997A8 (en) | Methods and compositions comprising ilex | |
| PT1730144E (pt) | Compostos de 1,4,8-triaza-espiro[4.5]decan-2-ona substituídos | |
| ATE419012T1 (de) | Verwendung von 2,5-dihydroxybenzolsulfonsäure- derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion | |
| WO2006041409A8 (en) | Medical solution, method for producing and use thereof | |
| WO2004010924A3 (en) | Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof | |
| ATE160938T1 (de) | Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung | |
| MXPA05008331A (es) | Derivados de 3-(benzoilureido)-tiofeno sustituido, metodo para su produccion y uso de los mismos. | |
| FR2834462B1 (fr) | Procede de preparation d'un principe actif vegetal, en particulier hydratant et a effet anti-rides, principe actif obtenu, composition et application en cosmetique | |
| WO2006071564A3 (en) | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents | |
| MY139947A (en) | Alpha-(1,4) linked glucose polymer containing oral compositions to alleviate or prevent tooth damage | |
| ATE449101T1 (de) | Salze von clopidogrel mit polyanionen und ihre verwendung zur herstellung pharmazeutischer formulierungen | |
| PT1815850E (pt) | Formulação de libertação controlada de ácido divalpróico e seus derivados | |
| WO2008006224A8 (en) | Medicagenic acid saponin and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |